- 全部删除
 您的购物车当前为空 您的购物车当前为空
WAY 316606 是一种分泌性糖蛋白Wnt 的拮抗剂,是一种分泌蛋白sFRP-1抑制剂,在 FP 结合检测使用中,它作用于 sFRP-1 的IC50为 0.5 μM。

WAY 316606 是一种分泌性糖蛋白Wnt 的拮抗剂,是一种分泌蛋白sFRP-1抑制剂,在 FP 结合检测使用中,它作用于 sFRP-1 的IC50为 0.5 μM。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 189 | In stock | |
| 5 mg | ¥ 448 | In stock | |
| 10 mg | ¥ 708 | In stock | |
| 25 mg | ¥ 1,300 | In stock | |
| 50 mg | ¥ 2,170 | In stock | |
| 100 mg | ¥ 3,160 | In stock | |
| 200 mg | ¥ 4,470 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 497 | In stock | 
WAY 316606 相关产品
| 产品描述 | WAY 316606 is an inhibitor of the secreted protein sFRP-1, an endogenous antagonist of the secreted glycoprotein Wnt. | 
| 靶点活性 |  SFRP1:0.5 μM | 
| 体外活性 | WAY-316606对U2-OS细胞中Wnt-Luciferase活性的EC50值为0.65 μM[1]。WAY-316606以0.08 μM的KD结合到分泌型frizzled相关蛋白(sFRP)-1抑制剂,并以0.65 μM的EC50抑制sFRP-1。同时,WAY-316606也能与sFRP-2结合,但结合能力弱于sFRP-1,其KD值为1 μM。使用一种含有荧光探针化合物的荧光偏振结合实验,并采用竞争结合方式对纯化的人sFRP-1蛋白进行测试,得出WAY-316606的IC50为0.5 μM [2]。 | 
| 体内活性 | WAY-316606在新生小鼠颅骨实验中能促进骨骼形成。该化合物以剂量依赖的方式显著增加总骨骼面积,高达60%,其中EC50约为1 nM。WAY-316606具有良好的水溶性、对细胞色素p450酶系(3A4、2D6、2C9)的中度至低度抑制作用,并在大鼠与人类肝微粒体中表现出良好稳定性(每种生物体中半衰期均>60分钟)。在雌性Sprague-Dawley大鼠中,经单次静脉注射给药(2 mg/kg)后,WAY-316606展现出高等于肝脏血流量的血浆清除率(77 mL/min/kg),导致无论给药途径如何,血浆中化合物暴露水平迅速下降[2]。 | 
| 激酶实验 | WAY-316606 binding to purified sFRP is determined by spectroscopy methods. The sFRP-1 or -2 stock solutions are diluted to 1 μM in a buffered solution and the initial fluorescence is measured. Increasing concentrations of WAY-316606 (0 to 50 μM) are added to the protein in the cuvette and incubated for 5 min prior to assessing fluorescence intensity using a Fluoromax-2 fluorometer. In control experiments, the DMSO (vehicle control)-matched buffer solution is used. Fluorescence spectra are scanned in the ratio mode (S/R, signal/reference) to compensate for variations in lamp output as a function of wavelength [2]. | 
| 细胞实验 | U2OS bone cells are infected with recombinant adenovirus 5 (Ad5)?WNT3 at a multiplicity of infection (MOI) of 2, followed by infection with Ad5-sFRP-1 and Ad5-16xTCF-luciferase, each at an MOI of 10. Four hours after infection, the cells are frozen in sterile cryogenic vials at a cell density of 9×106 cells/mL and stored in a ?150°C freezer. For the assay, a vial of frozen cells is thawed, and the cells are resuspended in plating medium [phenol red-free RPMI 1640 medium containing 5% fetal calf serum, 2 mM GlutaMAX-l, and 1% (v/v) penicillin-streptomycin] to a final cell density of 1.5×105 cells/mL. The resuspended cells are then plated in 96-well tissue culture treated plates at a volume of 100 μL of cell suspension/well (i.e., 1.5×104 cells/well). The plates are incubated at 37°C inside a 5% CO2/ 95% humidified air incubator for 5 h or until the cells have attached and started to spread. Prior to the addition of WAY-316606, the medium is replaced with 50 μL/well of phenol red-free RPMI 1640 containing 10% fetal calf serum, 2 mM GlutaMAX-l, and 1% (v/v) penicillin-streptomycin. WAY-316606, or vehicle (typically DMSO), diluted in phenol red-free RPMI 1640 containing 2 mM GlutaMAX-l, and l % (v/v) penicillin-streptomycin are then added to the wells in replicates of 4 wells/dilution and the plates are incubated at 37°C overnight. Dose?response experiments are performed with the compounds in 2-fold serial dilutions from 10000?4.9 nM. After the overnight incubation, the cells are washed twice with 150 uL/well of PBS w/o calcium or magnesium and lysed with 50 μL/well of 1× cell culture lysis reagent on a shaker at room temperature for 30 min. Aliquots of the cell lysates (30 μL) are transferred to 96-well luminometer plates, and the luciferase activity is measured in a MicroLumat PLUS luminometer using 100 μL/well of a luciferase substrate. | 
| 分子量 | 448.48 | 
| 分子式 | C18H19F3N2O4S2 | 
| CAS No. | 915759-45-4 | 
| Smiles | FC(F)(F)c1ccc(cc1S(=O)(=O)NC1CCNCC1)S(=O)(=O)c1ccccc1 | 
| 密度 | 1.50 g/cm3 (Predicted) | 
| 颜色 | White | 
| 物理性状 | Solid | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (111.49 mM), Sonication is recommended.   | |||||||||||||||||||||||||||||||||||
| 溶液配制表 | ||||||||||||||||||||||||||||||||||||
| DMSO 
 | ||||||||||||||||||||||||||||||||||||
 比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,
比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μL ,  一共给药动物 10 只 ,您使用的配方为 5%
 一共给药动物 10 只 ,您使用的配方为 5%  DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。
DMSO+ 30%PEG300+ 5%Tween 80 + 60%Saline/PBS/ddH2O, 那么您的工作液浓度为 2 mg/mL 。 
评论内容